A research group at Uppsala University has determined how CRISPR-Cas9 searches the genome for a specific DNA sequence. According to the team, this finding has implications for how Cas9 can be improved to make the technique faster and more reliable. The study is published in Science today.
“Most proteins that search DNA code can recognize one specific sequence merely by sensing the outside of the DNA double helix. Cas9 can search for an arbitrary code, but to determine whether it is in the right place the molecule has to open the double DNA helix and compare the sequence with the programmed code. The incredible thing is that it can still search the entire genome without using any energy,” says Johan Elf, who is in charge of the study.
The researchers developed two new methods to measure how long Cas9 takes to find its target sequence. The first method showed that it takes as long as six hours for Cas9 to search a bacterium, i.e., through four million base pairs. This result was also verifiable by means of the second, independent technique. The time found also tallies with the number of milliseconds Cas9 has available for testing every position, which the researchers were able to measure by following labeled Cas9 molecules in real time.
“The results show that the price Cas9 pays for its flexibility is time. To find the target faster, more Cas9 molecules searching for the same DNA sequence are needed,” adds Elf.
The very high concentrations of Cas9 that are necessary for finding the right sequence within a reasonable time frame can pose severe problems for the cells that scientists try to alternate. But since the nature of the search process is now understood, an important clue as to how the system can be improved has been found. By sacrificing a portion of Cas9's flexibility, it would be possible to design genetic scissors that are still sufficiently versatile to edit various genes but simultaneously fast enough to be medically usable.
“The results have given us clues on how we might achieve that kind of solution,” Elf explains. “The key is in what are known as the PAM sequences, which determine where and how often Cas9 opens up the DNA double helix. Molecular scissors that do not need to open the helix as many times to find their target are not only faster but would also reduce the risk of side-effects."